Drug intelligence / Profile preview

Omeganol

Development stage
Unknown
Lead developer
RIA Panda
Modality
Small Molecules
Administration
Oral
01

Overview

Omeganol is a multi-ingredient dietary supplement formulated to support cardiovascular health and lipid metabolism. Its primary active ingredients typically include omega-3 polyunsaturated fatty acids (eicosapentaenoic acid and docosahexaenoic acid), allicin (derived from garlic extract), and fat-soluble vitamins such as Vitamin E and Vitamin A. The omega-3 components function as ligands for peroxisome proliferator-activated receptors (PPARs), particularly PPAR-alpha, leading to reduced triglyceride synthesis and improved lipid profiles. Allicin contributes antioxidant properties and may help inhibit cholesterol biosynthesis, while Vitamin E protects cell membranes from oxidative damage. It is primarily indicated for the prevention of atherosclerosis and the management of hyperlipidemia, and it is widely marketed in Eastern European and Russian markets.

Brand names
Omeganol
Other names
Omeganol-800Omeganol800Omeganol 800
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)SREBP-1 / SREBF1 (SREBP-1)

Beyond the preview

Go deeper on Omeganol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omeganol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call